A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Preterm Infants.
Public ClinicalTrials.gov record NCT02878330. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Preterm Infants
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy, safety, pharmacokinetics (PK), and antidrug antibody (ADA) response for MEDI8897 in healthy preterm infants who are between 29 and 35 weeks gestational age (GA) and entering their first Respiratory Syncytial Virus (RSV) season.
Study identification
- NCT ID
- NCT02878330
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 1,453 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Up to 365 Days
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 3, 2016 (Actual)
- Primary completion
- Jul 17, 2018 (Actual)
- Completion
- Dec 6, 2018 (Actual)
- Last update posted
- Oct 14, 2019
2016 – 2018
United States locations
- U.S. sites
- 60
- U.S. states
- 27
- U.S. cities
- 56
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | 35205 | — |
| Research Site | Anaheim | California | 92804 | — |
| Research Site | Anaheim | California | 92805 | — |
| Research Site | Downey | California | 90241 | — |
| Research Site | Long Beach | California | 90806 | — |
| Research Site | Los Angeles | California | 90027 | — |
| Research Site | Paramount | California | 90723 | — |
| Research Site | San Diego | California | 92123 | — |
| Research Site | West Covina | California | 91790 | — |
| Research Site | Aurora | Colorado | 80045 | — |
| Research Site | Colorado Springs | Colorado | 80922 | — |
| Research Site | Hartford | Connecticut | 06106 | — |
| Research Site | Gainesville | Florida | 32607 | — |
| Research Site | Orlando | Florida | 32806 | — |
| Research Site | South Miami | Florida | 33143 | — |
| Research Site | Atlanta | Georgia | 30322 | — |
| Research Site | Augusta | Georgia | 30912 | — |
| Research Site | Chicago | Illinois | 60611 | — |
| Research Site | Oak Lawn | Illinois | 60068 | — |
| Research Site | Park Ridge | Illinois | 60068 | — |
| Research Site | South Bend | Indiana | 46601 | — |
| Research Site | Woburn | Massachusetts | 01801 | — |
| Research Site | Detroit | Michigan | 48201 | — |
| Research Site | Jackson | Mississippi | 39216 | — |
| Research Site | Columbia | Missouri | 65212 | — |
| Research Site | Lincoln | Nebraska | 68504 | — |
| Research Site | Omaha | Nebraska | 68124 | — |
| Research Site | Omaha | Nebraska | 68134 | — |
| Research Site | Omaha | Nebraska | 68198 | — |
| Research Site | Mineola | New York | 11501 | — |
| Research Site | New Hyde Park | New York | 11040 | — |
| Research Site | Stony Brook | New York | 11794 | — |
| Research Site | Syracuse | New York | 13210-2306 | — |
| Research Site | Boone | North Carolina | 28607 | — |
| Research Site | Raleigh | North Carolina | 27609 | — |
| Research Site | Cincinnati | Ohio | 45229 | — |
| Research Site | Cleveland | Ohio | 44109 | — |
| Research Site | Columbus | Ohio | 43205 | — |
| Research Site | Columbus | Ohio | 43231 | — |
| Research Site | Dayton | Ohio | 45414 | — |
| Research Site | Oklahoma City | Oklahoma | 73104 | — |
| Research Site | Gresham | Oregon | 97030 | — |
| Research Site | Erie | Pennsylvania | 16506 | — |
| Research Site | Pittsburgh | Pennsylvania | 15224 | — |
| Research Site | Charleston | South Carolina | 29425 | — |
| Research Site | North Charleston | South Carolina | 29406 | — |
| Research Site | Sioux Falls | South Dakota | 57104 | — |
| Research Site | Memphis | Tennessee | 38103 | — |
| Research Site | Edinburg | Texas | 78539 | — |
| Research Site | Fort Worth | Texas | 76107 | — |
| Research Site | Galveston | Texas | 77555 | — |
| Research Site | Longview | Texas | 75605 | — |
| Research Site | San Antonio | Texas | 78249 | — |
| Research Site | Layton | Utah | 84041 | — |
| Research Site | Orem | Utah | 84057 | — |
| Research Site | Syracuse | Utah | 84075 | — |
| Research Site | Seattle | Washington | 98105 | — |
| Research Site | Huntington | West Virginia | 25701 | — |
| Research Site | Morgantown | West Virginia | 26506 | — |
| Research Site | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 101 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02878330, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 14, 2019 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02878330 live on ClinicalTrials.gov.